[go: up one dir, main page]

Pinkas-Kramarski et al., 1998 - Google Patents

ErbB tyrosine kinases and the two neuregulin families constitute a ligand-receptor network

Pinkas-Kramarski et al., 1998

View HTML
Document ID
9519736412475427429
Author
Pinkas-Kramarski R
Shelly M
Guarino B
Wang L
Lyass L
Alroy I
Alamandi M
Kuo A
Moyer J
Lavi S
Eisenstein M
Ratzkin B
Seger R
Bacus S
Pierce J
Andrews G
Yarden Y
Publication year
Publication venue
Molecular and cellular biology

External Links

Snippet

The recently isolated second family of neuregulins, NRG2, shares its primary receptors, ErbB-3 and ErbB-4, and induction of mammary cell differentiation with NRG1 isoforms, suggesting functional redundancy of the two growth factor families. To address this …
Continue reading at pmc.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/4756—Neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/746—Erythropoetin

Similar Documents

Publication Publication Date Title
Pinkas-Kramarski et al. ErbB tyrosine kinases and the two neuregulin families constitute a ligand-receptor network
Harari et al. Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase
Burden et al. Neuregulins and their receptors: a versatile signaling module in organogenesis and oncogenesis
Tzahar et al. Pathogenic poxviruses reveal viral strategies to exploit the ErbB signaling network
Tzahar et al. ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all Neu differentiation factor/heregulin isoforms.
Pinkas‐Kramarski et al. Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions.
Lenferink et al. Differential endocytic routing of homo‐and hetero‐dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers
Muthuswamy et al. Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo-and heterodimers
Hackel et al. Epidermal growth factor receptors: critical mediators of multiple receptor pathways
Alimandi et al. Epidermal growth factor and betacellulin mediate signal transduction through co‐expressed ErbB2 and ErbB3 receptors
Shelly et al. Epiregulin is a potent pan-ErbB ligand that preferentially activates heterodimeric receptor complexes
Pinkas-Kramarski et al. The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin
Waterman et al. The C‐terminus of the kinase‐defective neuregulin receptor ErbB‐3 confers mitogenic superiority and dictates endocytic routing
Meyer et al. Isoform-specific expression and function of neuregulin
Tzahar et al. Bivalence of EGF‐like ligands drives the ErbB signaling network
Hynes et al. The ErbB receptor tyrosine family as signal integrators.
Pinkas-Kramarski et al. ErbB receptors and EGF-like ligands: cell lineage determination and oncogenesis through combinatorial signaling
Yarden Biology of HER2 and its importance in breast cancer
Wang et al. ErbB2 expression increases the spectrum and potency of ligand-mediated signal transduction through ErbB4
Kinugasa et al. Neuroglycan C, a novel member of the neuregulin family
Elenius et al. Characterization of a naturally occurring ErbB4 isoform that does not bind or activate phosphatidyl inositol 3-kinase
Watanabe et al. Recombinant human betacellulin. Molecular structure, biological activities, and receptor interaction
Riese et al. The cellular response to neuregulins is governed by complex interactions of the erbB receptor family
Yarden et al. Untangling the ErbB signalling network
AU722178B2 (en) Chimeric heteromultimer adhesins